Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1986 1
1988 2
1989 1
1990 2
1993 3
1994 2
1995 2
1996 1
1997 2
1998 1
2000 1
2001 1
2003 1
2006 1
2007 2
2009 3
2010 1
2011 1
2012 1
2013 2
2014 3
2015 9
2016 3
2017 6
2018 4
2019 8
2020 3
2021 3
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
Petrie JR, Chaturvedi N, Ford I, Brouwers MCGJ, Greenlaw N, Tillin T, Hramiak I, Hughes AD, Jenkins AJ, Klein BEK, Klein R, Ooi TC, Rossing P, Stehouwer CDA, Sattar N, Colhoun HM; REMOVAL Study Group. Petrie JR, et al. Among authors: hramiak i. Lancet Diabetes Endocrinol. 2017 Aug;5(8):597-609. doi: 10.1016/S2213-8587(17)30194-8. Epub 2017 Jun 11. Lancet Diabetes Endocrinol. 2017. PMID: 28615149 Free PMC article. Clinical Trial.
Evaluation of Visidex.
Paulshock BZ, Snyder M, Bernstein RI, Rubin AL, Bleicher SJ, Chowdry M, Hramiak I, Worthman J. Paulshock BZ, et al. Among authors: hramiak i. Diabetes Care. 1983 Nov-Dec;6(6):617-8. doi: 10.2337/diacare.6.6.617. Diabetes Care. 1983. PMID: 6653319 No abstract available.
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
McInnes N, Hall S, Lochnan HA, Harris SB, Punthakee Z, Sigal RJ, Hramiak I, Azharuddin M, Liutkus JF, Yale JF, Sultan F, Smith A, Otto RE, Sherifali D, Liu YY, Gerstein HC; REMIT-iGlarLixi Collaborative Group. McInnes N, et al. Among authors: hramiak i. Diabetes Obes Metab. 2023 Nov;25(11):3347-3355. doi: 10.1111/dom.15234. Epub 2023 Aug 14. Diabetes Obes Metab. 2023. PMID: 37580972 Clinical Trial.
Progression of glucose-lowering diabetes therapy in TECOS.
Bethel MA, Engel SS, Stevens SR, Lokhnygina Y, Ding J, Josse RG, Alvarsson M, Hramiak I, Green JB, Peterson ED, Holman RR; TECOS Study Group. Bethel MA, et al. Among authors: hramiak i. Endocrinol Diabetes Metab. 2018 Dec 22;2(1):e00053. doi: 10.1002/edm2.53. eCollection 2019 Jan. Endocrinol Diabetes Metab. 2018. PMID: 30815579 Free PMC article.
Teaching strategies in diabetic patients.
Hramiak IM. Hramiak IM. Diabetes Care. 1986 Nov-Dec;9(6):674-5. doi: 10.2337/diacare.9.6.674. Diabetes Care. 1986. PMID: 3803159 No abstract available.
70 results